美国 · SEC FORM 4
MARAVAI LIFESCIENCES HOLDINGS, INC.
MRVI · Nasdaq · CIK 0001823239 · Healthcare · Biotechnology
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
22 同一窗口内观察到的 Form 4 交易行
2 sales · 20 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2025-12-08 · LUCIER GREGORY T · $178.1K
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出较低
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Brust BerndChief Executive Officer
○○○○○
Asarpota RajeshChief Financial Officer
○○○○
ORESHACK KURTGeneral Counsel
○▼▼
LUCIER GREGORY TDirector
○○○
MARKER LUKE JOSEPHDirector
○
GRAY SUSANNAHDirector
○
● 买入▼ 卖出○ 其他
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-12-08 · LUCIER GREGORY T.
近期 Form 4 活动
5买入
2卖出
25其他 Form 4 交易行
29SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出2 sale line(s) · 仅供背景
其他20 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 13,826,066
- 上期报告
- 12,372,302
- 日均成交量
- 2,341,522
- 回补天数
- 5.9
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-12-08 | LUCIER GREGORY T | 买入 (P) | Class A Common Stock | 48,528 | USD 3.67 | USD 178,098 | SEC 申报 ↗ |
| 2025-12-05 | LUCIER GREGORY T | 买入 (P) | Class A Common Stock | 51,472 | USD 3.70 | USD 190,446 | SEC 申报 ↗ |
| 2025-11-13 | Brust Bernd | 买入 (P) | Class A Common Stock | 216,212 | USD 3.25 | USD 702,689 | SEC 申报 ↗ |
| 2025-11-12 | Brust Bernd | 买入 (P) | Class A Common Stock | 93,358 | USD 3.21 | USD 299,679 | SEC 申报 ↗ |
| 2025-11-11 | Brust Bernd | 买入 (P) | Class A Common Stock | 157,201 | USD 3.24 | USD 509,331 | SEC 申报 ↗ |
| 2024-11-12 | DeFord John A | 买入 (P) | Class A Common Stock | 17,500 | USD 5.75 | USD 100,625 | SEC 申报 ↗ |
| 2024-11-11 | HULL CARL | 买入 (P) | Class A Common Stock | 175,000 | USD 5.64 | USD 987,000 | SEC 申报 ↗ |
| 2020-11-25 | HULL CARL | 买入 (P) | Class A Common Stock | 35,000 | USD 26.94 | USD 942,900 | SEC 申报 ↗ |
| 2020-11-24 | SELLERS LISA | 买入 (P) | Class A Common Stock | 18,888 | USD 27.00 | USD 509,976 | SEC 申报 ↗ |
| 2020-11-24 | PRAHALAD MURALI | 买入 (P) | Class A Common Stock | 18,000 | USD 27.00 | USD 486,000 | SEC 申报 ↗ |
| 2020-11-24 | ORESHACK KURT | 买入 (P) | Class A Common Stock | 7,500 | USD 27.00 | USD 202,500 | SEC 申报 ↗ |
| 2020-11-24 | LUCIER GREGORY T | 买入 (P) | Class A Common Stock | 15,000 | USD 27.00 | USD 405,000 | SEC 申报 ↗ |
| 2020-11-24 | Hopfield Jessica | 买入 (P) | Class A Common Stock | 50,000 | USD 27.00 | USD 1,350,000 | SEC 申报 ↗ |
| 2020-11-24 | Hance Robert B | 买入 (P) | Class A Common Stock | 10,000 | USD 27.00 | USD 270,000 | SEC 申报 ↗ |
| 2020-11-24 | GRAY SUSANNAH | 买入 (P) | Class A Common Stock | 20,000 | USD 27.00 | USD 540,000 | SEC 申报 ↗ |
Form 4 申报证据
32 transaction lines in the latest 365-day window; 212 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | Brust Bernd | 代扣税 (F) | Class A Common Stock | 29,250 | USD 7.43 | USD 217,328 | SEC 申报 ↗ |
| 2026-09-30 | Asarpota Rajesh | 代扣税 (F) | Class A Common Stock | 5,465 | USD 7.65 | USD 41,807 | SEC 申报 ↗ |
| 2026-09-08 | Brust Bernd | 代扣税 (F) | Class A Common Stock | 29,250 | USD 7.32 | USD 214,110 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | Brust Bernd | 代扣税 (F) | Class A Common Stock | 29,250 | USD 7.43 | USD 217,328 | SEC 申报 ↗ |
| 2026-09-30 | Asarpota Rajesh | 代扣税 (F) | Class A Common Stock | 5,465 | USD 7.65 | USD 41,807 | SEC 申报 ↗ |
| 2026-09-08 | Brust Bernd | 代扣税 (F) | Class A Common Stock | 29,250 | USD 7.32 | USD 214,110 | SEC 申报 ↗ |
| 2026-08-31 | Asarpota Rajesh | 代扣税 (F) | Class A Common Stock | 5,465 | USD 7.68 | USD 41,971 | SEC 申报 ↗ |
| 2026-08-10 | Brust Bernd | 代扣税 (F) | Class A Common Stock | 29,250 | USD 6.23 | USD 182,228 | SEC 申报 ↗ |
| 2026-07-30 | Asarpota Rajesh | 代扣税 (F) | Class A Common Stock | 5,465 | USD 6.59 | USD 36,014 | SEC 申报 ↗ |
| 2026-07-08 | Brust Bernd | 代扣税 (F) | Class A Common Stock | 29,250 | USD 5.92 | USD 173,160 | SEC 申报 ↗ |
| 2026-06-30 | Asarpota Rajesh | 代扣税 (F) | Class A Common Stock | 65,584 | USD 6.39 | USD 419,082 | SEC 申报 ↗ |
| 2026-06-10 | ORESHACK KURT | 卖出 (S) | Class A Common Stock | 25,000 | USD 5.10 | USD 127,500 | SEC 申报 ↗ |
| 2026-06-09 | ORESHACK KURT | 卖出 (S) | Class A Common Stock | 25,000 | USD 5.06 | USD 126,500 | SEC 申报 ↗ |
| 2026-06-09 | LUCIER GREGORY T | 赠与 (G) | Class A Common Stock | 46,293 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-08 | Brust Bernd | 代扣税 (F) | Class A Common Stock | 351,001 | USD 5.02 | USD 1,762,025 | SEC 申报 ↗ |
| 2026-05-26 | MIHAS CONSTANTINE S | 奖励／授予 (A) | Class A Common Stock | 46,293 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-26 | MARKER LUKE JOSEPH | 奖励／授予 (A) | Class A Common Stock | 46,293 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-26 | LUCIER GREGORY T | 奖励／授予 (A) | Class A Common Stock | 46,293 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-26 | LUCIER GREGORY T | 奖励／授予 (A) | Class A Common Stock | 46,293 | USD 4.38 | USD 202,763 | SEC 申报 ↗ |
| 2026-05-26 | GRAY SUSANNAH | 奖励／授予 (A) | Class A Common Stock | 46,293 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-26 | ECKERT R ANDREW | 奖励／授予 (A) | Class A Common Stock | 46,293 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-26 | DeFord John A | 奖励／授予 (A) | Class A Common Stock | 46,293 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-26 | CUNNINGHAM SEAN LAURENCE | 奖励／授予 (A) | Class A Common Stock | 46,293 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-15 | ORESHACK KURT | 奖励／授予 (A) | Class A Common Stock | 776 | USD 2.84 | USD 2,204 | SEC 申报 ↗ |
| 2026-05-15 | Dolan Christine | 奖励／授予 (A) | Class A Common Stock | 5,006 | USD 1.79 | USD 8,961 | SEC 申报 ↗ |
| 2026-03-16 | ORESHACK KURT | 代扣税 (F) | Class A Common Stock | 39,976 | USD 3.08 | USD 123,126 | SEC 申报 ↗ |
| 2026-03-16 | Dolan Christine | 代扣税 (F) | Class A Common Stock | 28,661 | USD 3.08 | USD 88,276 | SEC 申报 ↗ |
| 2026-01-15 | ORESHACK KURT | 代扣税 (F) | Class A Common Stock | 31,902 | USD 3.69 | USD 117,718 | SEC 申报 ↗ |
| 2026-01-15 | Dolan Christine | 代扣税 (F) | Class A Common Stock | 28,934 | USD 3.69 | USD 106,766 | SEC 申报 ↗ |
| 2025-12-08 | LUCIER GREGORY T | 买入 (P) | Class A Common Stock | 48,528 | USD 3.67 | USD 178,098 | SEC 申报 ↗ |
| 2025-12-05 | LUCIER GREGORY T | 买入 (P) | Class A Common Stock | 51,472 | USD 3.70 | USD 190,446 | SEC 申报 ↗ |
| 2025-11-14 | Dolan Christine | 奖励／授予 (A) | Class A Common Stock | 4,300 | USD 1.79 | USD 7,697 | SEC 申报 ↗ |
| 2025-11-13 | Brust Bernd | 买入 (P) | Class A Common Stock | 216,212 | USD 3.25 | USD 702,689 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | MRVI |
| CIK | 0001823239 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 212 transaction lines from 2020-11-19 to 2026-10-08 15 P purchase lines · 4 S sale lines · 193 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.